Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. (Q53851020)

20 May 2018

title

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. (English)

1 reference

20 May 2018

1 reference

1

1 reference

20 May 2018

Emmanouil Magiorkinis

2

1 reference

20 May 2018

author name string

A Katsoulidou

3

1 reference

20 May 2018

E Hatzitheodorou

4

1 reference

20 May 2018

A Antoniadou

5

1 reference

20 May 2018

A Papadopoulos

6

1 reference

20 May 2018

G Poulakou

7

1 reference

20 May 2018

V Paparizos

8

1 reference

20 May 2018

C Botsi

9

1 reference

20 May 2018

N Stavrianeas

10

1 reference

20 May 2018

M Lelekis

11

1 reference

20 May 2018

M Chini

12

1 reference

20 May 2018

P Gargalianos

13

1 reference

20 May 2018

N Magafas

14

1 reference

20 May 2018

M Lazanas

15

1 reference

20 May 2018

G Chryssos

16

1 reference

20 May 2018

G Petrikkos

17

1 reference

20 May 2018

G Panos

18

1 reference

20 May 2018

T Kordossis

19

1 reference

20 May 2018

M Theodoridou

20

1 reference

20 May 2018

V Sypsa

21

1 reference

20 May 2018

A Hatzakis

22

1 reference

20 May 2018

Hellenic Multi-centre study on HIV-resistance

23

1 reference

20 May 2018

publication date

8 April 2005

1 reference

20 May 2018

published in

Virus Research

1 reference

20 May 2018

volume

112

1 reference

20 May 2018

issue

1-2

1 reference

20 May 2018

page(s)

115-122

1 reference

20 May 2018

Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

HIV-1 drug resistance in newly infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Bayesian inference of phylogeny and its impact on evolutionary biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Genetic characterization of HIV-1 strains in the Baltic countries and Russia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Antiretroviral-drug resistance among patients recently infected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Impact of drug resistance mutations on virologic response to salvage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

Transmission of antiretroviral-drug-resistant HIV-1 variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.004

10.1016/J.VIRUSRES.2005.03.004

7 January 2021

Identifiers

DOI

1 reference

20 May 2018

PubMed ID

16022906

1 reference

20 May 2018